Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone

Journal of the European Academy of Dermatology and Venereology

Volumn 10, Issue 2, 1998, Pages 137-142

  Hoffmann, K ^a   Auer, T ^a   Stucker M ^a   Hoffmann, A ^a   Altmeyer, P ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Chromometry; Laser Doppler; Methylprednisolone; Mometasone furoate; Skin atrophy; Sonography; Tachyphylaxis; Vasoconstriction

Indexed keywords

BETAMETHASONE DIPROPIONATE; DIPROSONE BASISCREME; DRUG VEHICLE; HYDROCORTISONE; HYDROCORTISONE WOLFF; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GOOD CLINICAL PRACTICE; GOOD LABORATORY PRACTICE; HUMAN; LASER DOPPLER FLOWMETRY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SKIN ATROPHY; SKIN BLOOD FLOW; SKIN BLOOD VESSEL; SKIN COLOR; SKINFOLD THICKNESS; TACHYPHYLAXIS; TOPICAL DRUG ADMINISTRATION; VASOCONSTRICTION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ATROPHY; FEMALE; HUMANS; HYDROCORTISONE; LASER-DOPPLER FLOWMETRY; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREGNADIENEDIOLS; SKIN; SPECTROPHOTOMETRY; VASOCONSTRICTION;

EID: 0031950819     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)00151-7     Document Type: Article

References (13)

1. Degreef H, Dooms-Goossens A. The new corticosteroids: are they effective and safe? Dermatol Clin 1993;11:155-160.
2. Kelly JW, Geoffrey DC, Railings M, Gilmore SJ. Safety and efficacy of mometasone furoate cream in the treatment of steroid responsive dermatoses. Australas J Dermatol 1991;32:85-91.
3. Vernon HJ, Lane AT, Weston W. Comparison of mometasone furoate 0.1% cream and hydrocortisone 0.1% cream in the treatment of childhood atopic dermatitis. J Am Dermatol 1991;24:603-607.
4. Stücker M, Auer T, Hoffmann K, Altmeyer P. Two-dimensional blood flow determinations in allergic reactions using laser Doppler scanning. Contact Dermatitis 1995;33:299-303.
5. el-Gammal S, Auer T, Hoffmann K, et al. Möglichkeiten und Grenzen der hochauflösenden (20 und 50 MHz) Sonographie in der Dermatologie. Aktuelle Dermatol 1992;18:197-208.
6. Hoffmann K, Auer T, Dirschka T, et al. Evaluation of the efficacy of H1-blockers by non-invasive measurement techniques. Dermatology 1994;189:146-151.
7. Waring MJ, Monger L, Hollingsbee DA, et al. Assessment of corticosteroid-inducing skin blanching: evaluation of the Minolta Chromometer CR200. Int J Pharm 1993;94:211-222.
8. Queille-Roussel C, Poncet M, Schaefer H. Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chromometer. Br J Dermatol 1991;124:264-270.
9. Utz SR. Optical properties of psoriatic epidermis. Acta Derm Venereol (Stockh) (Suppl) 1994;186:37.
10. Bisgaard H, Kreistensen JK, Sondergaard J. A new technique for ranking vascular corticosteroid effects in human using laser Doppler velocimeter. J Invest Dermatol 1986;86:275-278.
11. Kristensen LK, Wadskov S, Henriksen O. Dose-dependent effect of topical corticosteroids on blood flow in human cutaneous tissue. Acta Derm Venereol (Stockh) 1978;58:145-148.
12. Andersen P, Milioni K, Maibach H. The cutaneous corticosteroid vasoconstriction assay: a reflectance spectroscopic and laser Doppler flowmetric study. Br J Dermatol 1993;128: 660-665.
13. Somerma S, Lassus A, Salde L. Assessment of atrophy of human skin caused by corticosteroids using chamber occlusion and suction blister techniques. Acta Derm Venereol (Stockh) 1984;64:41-45.